11 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Obstructive Lung Disease ... LAMA: long-acting ... muscarinic antagonist; LABA ... #Management #Pulmonary ... #LAMA #LABA #ICS
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
disease (COPD) ... corticosteroid; LABA ... long-acting β2-agonist; LAMA ... #COPD #Treatment ... #Pulmonary #LABA
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
to respiratory risk ... corticosteroids; LABA ... long-acting β2-agonist; LAMA ... #Diagnosis #Management ... Differences #Algorithm #Treatment
Chronic Obstructive Pulmonary Disease (COPD)
 • COPD Definition
 • Role of PFTs
 • COPD Classification and
Disease (COPD) ... post-bronchodilator FEV1 ... #Disease #COPD ... #diagnosis #management ... #GOLD2022 #treatment
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... pneumonia • DM risk ... Cryptococcus - Coccidioides ... Lung #Abscess #pulmonary ... #treatment #diagnosis
Coccidioidomycosis (Coccidioides): Valley Fever - Summary Sheet
 • Morphology
 • Geography, Reservoir and Mode of Transmission
Coccidioidomycosis (Coccidioides ... Americans at higher risk ... meninges and spinal cord ... • Management ... disease: no treatment
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... days before Pulmonary ... Determine if any labs ... medical and surgical management ... stratification #diagnosis
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Valvular heart disease ... cardiomyopathy • Pulmonary ... teratogenic GDMT meds ... #treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... effusion, INC risk ... Malignancy Risk ... Adenocarcinoma Treatment ... #Management
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
identified (autoimmune, meds ... , neoplastic) TREATMENT ... steroids for severe disease ... TylerLarsenMD #COP ... #management #pulmonary